There is a growing body of research investigating the health effects of PFOS in humans and animals, including the reproductive, developmental, liver, kidney, thyroid, and immunological effects. According to a 2002 report by the Environmental Directorate of the
OECD, "PFOS is
persistent, bioaccumulative, and toxic to mammalian species."
Pregnancy outcomes Several studies have focused on pregnancy outcomes in infants and mothers who are exposed to PFOS during pregnancy. For developing offspring, exposure to PFOS occurs through the placenta. There has been some evidence to suggest that PFOS levels in pregnant women have been associated with
preeclampsia,
preterm labor,
low birth weight and
gestational diabetes. Although, the strongest association is between PFOS levels with preterm birth and preeclampsia. There has been some evidence to suggest that PFOS impairs fetal growth during pregnancy, although findings have been inconsistent. Additionally, PFOS exposure has been shown to be related to the downregulation genes corresponding to growth factors, pregnancy-related signal transducers, and maternal hormones. PFOS impact on thyroid hormone regulation also has the potential to impact several birth outcomes.
Breastfeeding and lactation PFOS has been measured in breastmilk and is estimated to contribute the greatest level of PFOS exposure in infants. Specifically, the duration of breastfeeding has been shown to be associated with increases in PFOS in infants. Some evidence has shown that breastmilk accounts for more than 94% of the PFOS exposure in infants up to six months old. The Agency for Toxic Substances and Disease Registry (ATSDR) concluded that breastfeeding benefits continue to outweigh potential risks associated with PFOS in breastmilk.
Thyroid disease Increased levels of PFOS have been shown to accumulate in
thyroid gland cells and have been associated with altered
thyroid hormone levels in adults. Appropriate levels of thyroid hormone during pregnancy are critical for a developing fetus as this hormone is involved with brain development and body growth. Studies have demonstrated a relationship between PFOS exposure and thyroid dysfunction during pregnancy resulting in altered thyroid hormone levels in both the mother and the fetus.
Hypercholesterolemia PFOS has been associated with increased risk of abnormal levels of
cholesterol. Specifically,
epidemiological studies in humans have reported an association between increased PFOS levels and the total cholesterol and
low density lipoprotein (LDL) cholesterol.
Chronic kidney disease Serum levels of PFOS were found to be associated with increased risk of
chronic kidney disease in the general US population. "This
association was independent of
confounders such as age, sex, race/ethnicity,
body mass index, diabetes, hypertension, and serum cholesterol level." The Division of Cancer Epidemiology & Genetics (DCEG) is currently investigating the association of several PFAS compounds and cancers including kidney cancer, testicular cancer, prostate cancer, ovarian and endometrial cancer, thyroid cancer, non-hodgkins lymphoma, and childhood leukemia.
In wildlife The levels observed in wild animals are considered sufficient to "alter health parameters". PFOS affects the
immune system of male mice at a
blood serum concentration of 91.5
parts per billion, raising the possibility that highly exposed people and wildlife are
immunocompromised. ==Regulation==